Related Experiment Video
Updated: Jun 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
The Ste20-like kinase SLK promotes p53 transactivation and apoptosis
Andrey V Cybulsky1, Tomoko Takano, Julie Guillemette
1Div. of Nephrology, Royal Victoria Hospital, 687 Pine Ave. West, Montreal, Quebec H3A1A1, Canada. andrey.cybulsky@mcgill.ca
Abstract:
Expression and activity of the germinal center kinase [corrected] SLK are increased during kidney development and recovery from renal ischemia-reperfusion injury. SLK promotes apoptosis, in part, via pathway(s) involving apoptosis signal-regulating kinase-1 and p38 mitogen-activated protein kinase. This study addresses the role of p53 as a potential effector of SLK. p53 transactivation was measured after transient transfection of a luciferase reporter plasmid that contains a p53 cis-acting enhancer element. Overexpression of SLK in COS-1 cells and cotransfection of SLK and p53-wild type (wt) cDNAs in glomerular epithelial cells (GECs) stimulated p53 transactivational activity, as measured by a p53 response element-driven luciferase reporter. In GECs, chemical anoxia followed by glucose reexposure (in vitro ischemia-reperfusion) increased p53 reporter activity, and this increase was amplified by overexpression of SLK. Expression of SLK induced p53 phosphorylation on serine (S)-33 and S315. In GECs, cotransfection of SLK with p53-wt, p53-S33A, p53-S315A, or p53-S33A+S315A mutants showed that only the double mutation abolished the SLK-induced increase in p53 reporter activity. SLK-induced stimulation of p53 reporter activity was attenuated by inhibition of JNK. Overexpression of SLK amplified apoptosis induced by subjecting cells to in vitro ischemia-reperfusion injury, while ectopic expression of a dominant negative SLK mutant attenuated the ischemia-reperfusion-induced apoptosis. The p53 transactivation inhibitor pifithrin-alpha significantly attenuated the amount of apoptosis after ischemia-reperfusion and SLK overexpression. Thus SLK induces p53 phosphorylation and transactivation, which enhances apoptosis after in vitro ischemia-reperfusion injury.
Insights
The study reveals that SLK kinase promotes kidney injury recovery by activating p53. This activation enhances apoptosis following renal ischemia-reperfusion injury, highlighting a key molecular pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Renal Pathophysiology
Background:
- Germinal center kinase SLK (Scratch-like kinase) activity increases during kidney development and after renal ischemia-reperfusion injury.
- SLK is known to promote apoptosis through pathways involving apoptosis signal-regulating kinase-1 and p38 mitogen-activated protein kinase.
- The role of p53 in the SLK-mediated apoptotic pathway remains to be fully elucidated.
Purpose of the Study:
- To investigate the role of p53 as a potential effector of SLK in the context of renal ischemia-reperfusion injury.
- To determine if SLK influences p53 transactivation and phosphorylation.
- To examine the impact of SLK-induced p53 activity on apoptosis.
Main Methods:
- Assessed p53 transactivation using a luciferase reporter assay with a p53 cis-acting enhancer element in COS-1 cells and glomerular epithelial cells (GECs).
- Induced in vitro ischemia-reperfusion injury in GECs via chemical anoxia and glucose reexposure.
- Analyzed p53 phosphorylation at specific serine residues (S33, S315) and utilized p53 mutants to identify key phosphorylation sites. Inhibited c-Jun N-terminal kinase (JNK) and p53 transactivation using pifithrin-alpha.
Main Results:
- Overexpression of SLK stimulated p53 transactivational activity in both COS-1 cells and GECs.
- In vitro ischemia-reperfusion injury increased p53 reporter activity in GECs, an effect amplified by SLK overexpression.
- SLK induced p53 phosphorylation at S33 and S315; only the double S33A+S315A mutation abolished SLK-induced p53 activity. JNK inhibition attenuated SLK-induced p53 activity.
- SLK overexpression enhanced apoptosis during in vitro ischemia-reperfusion, while a dominant-negative SLK mutant reduced it. Pifithrin-alpha inhibited apoptosis.
Conclusions:
- SLK induces p53 phosphorylation at S33 and S315, leading to enhanced p53 transactivation.
- The SLK-p53 pathway, particularly involving JNK signaling, plays a critical role in promoting apoptosis following renal ischemia-reperfusion injury.
- Targeting the SLK-p53 interaction may offer a therapeutic strategy for mitigating kidney injury.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Extrinsic Apoptotic Pathway
